Furthermore, a combination of TGF‐β1R signaling blockage and cGAMP treatment could control tumor growth significantly (Figure 6B,C), confirming that elevated TGF‐β levels hijacked γδ T cell effector function during the late stage of tumor progression. The gene discussed is TGFB1; the disease is neoplasm.